Table 1.
General characteristics of AAV patients and healthy controls.
| AAV patients | Healthy controls | P | |
|---|---|---|---|
| (n = 79) | (n = 76) | ||
| Age, year | 65 ± 12.17 | 62 ± 9.56 | >0.05 |
| Gender (male), % | 39.49% | 31.41% | >0.05 |
| White blood cell count, 109/L | 8.2 (5.46, 11.38) | 5.59 ± 1.27 | <0.0001 |
| Red blood cell count, 1012/L | 3.05 ± 0.90 | 4.16 ± 0.47 | <0.0001 |
| Platelet count, /L | 269.33 ± 124.54 | 202.30 ± 48.45 | <0.0001 |
| Mean platelet volume, fl | 9.98 ± 1.50 | 11.04± 1.57 | <0.05 |
| Plateletcrit, % | 0.53 ± 0.10 | 0.21 (0.19, 0.24) | <0.05 |
| Neutrophil percentage, % | 75.15 ± 9.64 | 56.03 ± 7.88 | <0.0001 |
| Lymphocyte percentage, % | 15.40 (11.00, 19.50) | 32.59 ± 7.86 | <0.0001 |
| CRP, mg/L | 23.90 (11.00, 61.60) | 2.32 (1.73, 3.02) | <0.0001 |
| CAR | 0.80 (0.38, 2.38) | 0.05 (0.04, 0.07) | <0.0001 |
| NLR | 5.01 (3.55, 7.63) | 1.80 (1.40, 2.21) | <0.0001 |
| BVAS | 15.65 ± 6.35 |
CAR, C-reactive protein/albumin ratio; NLR, neutrophil/lymphocyte ratio; ANCA, anti-neutrophil cytoplasmic antibody (ANCA); MPO, myeloperoxidase; PR3, proteinase 3; P, perinuclear type; C, cytoplasmic type; BVAS, Birmingham Vasculitis Activity Score.
Data are expressed as mean ± standard deviation, as median (inter-quartile range), or as numbers (%).